TI
Trimedyne Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by LOEB MARVIN P, was filed 26 Jan 2009.
Trimedyne Inc: what insiders have been doing
Trimedyne Inc is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Trimedyne Inc has published a filing in the past twelve months. The most recent one dates from 26 January 2009.
Our records for Trimedyne Inc go back to 2006, with 3 purchases and 6 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
15
Thresholds
n/a
Buy Volume
€28,799
3 ops. · all time
Sell Volume
€21,945
6 ops. · all time
Financial data
as of FY 2015FY ended September 2015 · cache
Income statement
Revenue1.2M
Gross profit1.6M137% margin
Net income-532.5k-45.9% margin
Last declaration on 26 January 2009
Declarations15 total
- 109,000 shares@ US$0.097Common StockSEC:0001019687-09-000281:0Canonical exit: 23 Mar 2009 (T+90)
- 100,000 shares@ US$0.11Common StockSEC:0001019687-08-005648:0Canonical exit: 16 Feb 2009 (T+90)
- 150,000 shares@ US$0.105Common StockSEC:0001019687-08-005648:1Canonical exit: 19 Feb 2009 (T+90)
- 100,000 sharesCommon StockSEC:0001019687-07-003655:0
- 5,000 shares@ US$1.15Common StockSEC:0001019687-07-001879:0
- 5,000 shares@ US$0.14Common StockSEC:0001019687-07-001879:1
- 1,500 shares@ US$1.71Common StockSEC:0001019687-07-001879:2
- 1,500 shares@ US$0.14Common StockSEC:0001019687-07-001879:3
- 9,500 shares@ US$1.09Common StockSEC:0001019687-06-001350:0
- 10,000 shares@ US$0.14Common StockSEC:0001019687-06-001350:2
- 500 shares@ US$1.10Common StockSEC:0001019687-06-001350:1
- 500 shares@ US$1.04Common StockSEC:0001019687-06-000550:0
- 500 shares@ US$0.14Common StockSEC:0001019687-06-000550:1
- 8,000 shares@ US$1.00Common StockSEC:0001019687-06-000550:2
- 8,000 shares@ US$0.14Common StockSEC:0001019687-06-000550:3
15 of 15 declarations
About Trimedyne Inc
Trimedyne Inc is a company listed on the XNAS market. It specializes in the development of innovative medical technologies.
